|
1
|
Hofsli E, Sjursen W, Prestvik WS, Johansen
J, Rye M, Tranø G, Wasmuth HH, Hatlevoll I and Thommesen L:
Identification of serum microRNA profiles in colon cancer. Br J
Cancer. 108:1712–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
National Comprehensive Cancer Network.
Guidelines for Treatment of Cancer By Site and Guidelines for
Dectection, Prevention, & Risk Reduction. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#siteAccessed.
December 24–2016.
|
|
3
|
Geiger TM and Ricciardi R: Screening
options and recommendations for colorectal cancer. Clin Colon
Rectal Surg. 22:209–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hol L, de Jonge V, van Leerdam ME, van
Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD,
Essink-Bot ML and Kuipers EJ: Screening for colorectal cancer:
Comparison of perceived test burden of guaiac-based faecal occult
blood test, faecal immunochemical test and flexible sigmoidoscopy.
Eur J Cancer. 46:2059–2066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
National Comprehensive Cancer Network.
Clinical Practice Guidelines in Oncology. Colon cancer Version 2.
2015 http://www.nccn.org/professionals/physician_gls/pdf/colon.pdfAccessed.
October 20–2015.
|
|
6
|
Baj-Krzyworzeka M, Szatanek R, Weglarczyk
K, Baran J, Urbanowicz B, Brański P, Ratajczak MZ and Zembala M:
Tumour-derived microvesicles carry several surface determinants and
mRNA of tumour cells and transfer some of these determinants to
monocytes. Cancer Immunol Immunother. 55:808–818. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deregibus MC, Cantaluppi V, Calogero R, Lo
Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B and Camussi G:
Endothelial progenitor cell derived microvesicles activate an
angiogenic program in endothelial cells by a horizontal transfer of
mRNA. Blood. 110:2440–2448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ratajczak J, Miekus K, Kucia M, Zhang J,
Reca R, Dvorak P and Ratajczak MZ: Embryonic stem cell-derived
microvesicles reprogram hematopoietic progenitors: Evidence for
horizontal transfer of mRNA and protein delivery. Leukemia.
20:847–856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim CW, Lee HM, Lee TH, Kang C, Kleinman
HK and Gho YS: Extracellular membrane vesicles from tumor cells
promote angiogenesis via sphingomyelin. Cancer Res. 62:6312–6317.
2002.PubMed/NCBI
|
|
11
|
Ratajczak J, Wysoczynski M, Hayek F,
Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived
microvesicles: Important and underappreciated mediators of
cell-to-cell communication. Leukemia. 20:1487–1495. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gould SJ, Booth AM and Hildreth JE: The
Trojan exosome hypothesis. Proc Natl Acad Sci USA. 100:10592–10597.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy
SL, Breakefield XO and Skog J: Tumour microvesicles contain
retrotransposon elements and amplified oncogene sequences. Nat
Commun. 2:1802011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HK, Song KS, Park YS, Kang YH, Lee YJ,
Lee KR, Kim HK, Ryu KW, Bae JM and Kim S: Elevated levels of
circulating platelet microparticles, VEGF, IL-6 and RANTES in
patients with gastric cancer: Possible role of a metastasis
predictor. Eur J Cancer. 39:184–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobayashi M, Salomon C, Tapia J, Illanes
SE, Mitchell MD and Rice GE: Ovarian cancer cell invasiveness is
associated with discordant exosomal sequestration of Let-7 miRNA
and miR-200. J Transl Med. 12:42014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao W, Dong W, Zhang C, Saren G, Geng P,
Zhao H, Li Q, Zhu J, Li G, Zhang S and Ye M: Effects of the
epigenetic drug MS-275 on the release and function of
exosome-related immune molecules in hepatocellular carcinoma cells.
Eur J Med Res. 18:612013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu P, Liang H, Xue L, Yang C, Liu Y, Zhou
K and Jiang X: Potential clinical significance of plasma-based KRAS
mutation analysis using the COLD-PCR/TaqMan(®)-MGB probe
genotyping method. Exp Ther Med. 4:109–112. 2012.PubMed/NCBI
|
|
21
|
Thierry AR, Mouliere F, El Messaoudi S,
Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte
P, Robert B, et al: Clinical validation of the detection of KRAS
and BRAF mutations from circulating tumor DNA. Nat Med. 20:430–435.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuo YB, Chen JS, Fan CW, Li YS and Chan
EC: Comparison of KRAS mutation analysis of primary tumors and
matched circulating cell-free DNA in plasmas of patients with
colorectal cancer. Clin Chin Acta. 433:284–289. 2014. View Article : Google Scholar
|
|
23
|
Perrone F, Lampis A, Bertan C, Verderio P,
Ciniselli CM, Pizzamiglio S, Frattini M, Nucifora M, Molinari F,
Gallino G, et al: Circulating free DNA in a screening program for
early colorectal cancer detection. Tumori. 100:115–121.
2014.PubMed/NCBI
|
|
24
|
Sorenson GD, Pribish DM, Valone FH, Memoli
VA, Bzik DJ and Yao SL: Soluble normal and mutated DNA sequences
from single-copy genes in human blood. Cancer Epidemiol Biomarkers
Prev. 3:67–71. 1994.PubMed/NCBI
|
|
25
|
Vasioukhim V, Anker P, Maurice P, Lyautery
J, Lederrey C and Stroun M: Point mutations of the N-ras gene in
the blood plasma DNA of patients with myelodysplastic syndrome or
acute myelogenous leukaemia. Br J Haematol. 86:774–779. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koyanagi K, Mori T, O'Day SJ, Martinez SR,
Wang HJ and Hoon DS: Association of circulating tumor cells with
serum tumor-related methylated DNA in peripheral blood of melanoma
patients. Cancer Res. 66:6111–6117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mori T, O'Day SJ, Umatani N, Martinez SR,
Kitago M, Koyanagi K, Kuo C, Takeshima TL, Milford R, Wang HJ, et
al: Predictive utility of circulating methylated DNA in serum of
melanoma patients receiving biochemotherapy. J Clin Oncol.
23:9351–9358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu M, Wang J, Xu Y, Ding X, Li M, Jiang
F, Xu L and Yin R: Circulating tumor DNA is effective for the
detection of EGFR mutation in non-small cell lung cancer: A
meta-analysis. Cancer Epidemiol Biomarkers Prev. 24:206–212. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fleischhacker M and Schmidt B: Circulating
nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta.
1775:181–232. 2007.PubMed/NCBI
|
|
30
|
Emlen W and Mannik M: Effect of DNA size
and strandedness on the in vivo clearance and organ localization of
DNA. Clin Exp Immunol. 56:185–192. 1984.PubMed/NCBI
|
|
31
|
Wimberger P, Roth C, Pantel K,
Kasimir-Bauer S, Kimmig R and Schwarzenbach H: Impact of
platinum-based chemotherapy on circulating nucleic acid levels,
protease activities in blood and disseminated tumor cells in bone
marrow of ovarian cancer patients. Int J Cancer. 128:2572–2580.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahlquist DA, Sargent DJ, Loprinzi CL,
Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ,
Hamilton SR, et al: Stool DNA and occult blood testing for screen
detection of colorectal neoplasia. Ann Intern Med. 149:441–450,
W481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Potack J and Itzkowitz SH: Practical
advances in stool screening for colorectal cancer. J Natl Compr
Canc Netw. 8:81–92. 2010.PubMed/NCBI
|
|
34
|
Ahlquist DA: Next-generation stool DNA
testing: Expanding the scope. Gastroenterology. 136:2068–2073.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Davies RJ, Miller R and Coleman N:
Colorectal cancer screening: Prospects for molecular stool
analysis. Nat Rev Cancer. 5:199–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cocucci E, Racchetti G and Meldolesi J:
Shedding microvesicles: Artefacts no more. Trends Cell Biol.
19:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body
fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol.
8:467–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zomer A, Vendrig T, Hopmans ES, van
Eijndhoven M, Middeldorp JM and Pegtel DM: Exosomes: Fit to deliver
small RNA. Commun Integr Biol. 3:447–450. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Russo F, Di Bella S, Nigita G, Macca V,
Laganà A, Giugno R, Pulvirenti A and Ferro A: miRandola:
Extracellular circulating microRNAs database. PLoS One.
7:e477862012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Caby MP, Lankar D, Vincendeau-Scherrer C,
Raposo G and Bonnerot C: Exosomal-like vesicles are present in
human blood plasma. Int Immunol. 17:879–887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Andre F, Schartz NE, Movassagh M, Flament
C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier
T, et al: Malignant effusions and immunogenic tumour-derived
exosomes. Lancet. 360:295–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bard MP, Hegmans JP, Hemmes A, Luider TM,
Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA,
Hoogsteden HC and Lambrecht BN: Proteomic analysis of exosomes
isolated from human malignant pleural effusions. Am J Respir Cell
Mol Biol. 31:114–121. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pisitkun T, Shen RF and Knepper MA:
Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci USA. 101:13368–13373. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kahlert C, Melo SA, Protopopov A, Tang J,
Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A and Kalluri R:
Identification of double-stranded genomic DNA spanning all
chromosomes with mutated KRAS and p53 DNA in the serum exosomes of
patients with pancreatic cancer. J Biol Chem. 289:3869–3875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guescini M, Guidolin D, Vallorani L,
Casadei L, Gioacchini AM, Tibollo P, Battistelli M, Falcieri E,
Battistin L, Agnati LF and Stocchi V: C2C12 myoblasts release
micro-vesicles containing mtDNA and proteins involved in signal
transduction. Exp Cell Res. 316:1977–1984. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Onco. 110:13–21. 2008. View Article : Google Scholar
|
|
49
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vickers KC, Palmisano BT, Shoucri BM,
Shamburek RD and Remaley AT: MicroRNAs are transported in plasma
and delivered to recipient cells by high-density lipoproteins. Nat
Cell Biol. 13:423–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Khalyfa A and Gozal D: Exosomal miRNAs as
potential biomarkers of cardiovascular risk in children. J Transl
Med. 12:1622014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Benvenuti S, Sartore-Bianchi A, Di
Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S and Bardelli
A: Oncogenic activation of the RAS/RAF signaling pathway impairs
the response of metastatic colorectal cancers to antie-epidermal
growth factor receptor antibody therapies. Cancer Res.
67:2643–2648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Neumann J, Zeindl-Eberhart E, Kirchner T
and Jung A: Frequency and type of KRAS mutations in routine
diagnostic analysis of metastatic colorectal cancer. Pathol Res
Pract. 205:858–862. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shen H, Yuan Y, Hu H, Zhong X, Ye XX, Li
MD, Fang WJ and Zheng S: Clinical significance of K-ras and BRAF
mutations in Chinese colorectal cancer patients. World J
Gastroenterol. 17:809–816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Silva J, Garcia V, Rodriguez M, Compte M,
Cisneros E, Veguillas P, Garcia JM, Dominguez G, Campos-Martin Y,
Cuevas J, et al: Analysis of exosome release and its prognostic
value in human colorectal cancer. Gens Chromosomes Cancer.
51:409–418. 2012. View Article : Google Scholar
|
|
56
|
Bisht S, Ahmad F, Sawaimoon S, Bhatia S
and Das BR: Molecular spectrum of KRAS, BRAF and PIK3CA gene
mutation: Determination of frequency, distribution pattern in
Indian colorectal carcinoma. Med Oncol. 31:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Phipps AI, Buchanan DD, Makar KW, Win AK,
Baron JA, Lindor NM, Potter JD and Newcomb PA: KRAS-mutation status
in relation to colorectal cancer survival: The joint impact of
correlated tumour markers. Br J Cancer. 108:1757–1764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen
H, Tang J and Chen Q: KRAS, BRAF and PIK3CA mutations and the loss
of PTEN expression in Chinese patients with colorectal cancer. PLoS
One. 7:e366532012. View Article : Google Scholar : PubMed/NCBI
|
